Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...

HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.

Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...